WEST PHARMACEUTICAL SERVICES INC Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
West Pharmaceutical Services Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2011 to Q3 2024.
  • West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.1M, a 13.6% decline year-over-year.
  • West Pharmaceutical Services Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $15.8M, a 44.8% decline year-over-year.
  • West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2023 was $23.3M, a 1.69% decline from 2022.
  • West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2022 was $23.7M, a 36.8% decline from 2021.
  • West Pharmaceutical Services Inc annual Share-based Payment Arrangement, Expense for 2021 was $37.5M, a 10.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $15.8M $5.1M -$800K -13.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $16.6M $4.3M -$3.2M -42.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $19.8M $5M -$3.5M -41.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $23.3M $1.4M -$5.3M -79.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $28.6M $5.9M -$100K -1.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 $28.7M $7.5M +$2M +36.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $26.7M $8.5M +$3M +54.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $23.7M $6.7M -$3.2M -32.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $26.9M $6M -$5.4M -47.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $32.3M $5.5M -$4.8M -46.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $37.1M $5.5M -$400K -6.78% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q4 2021 $37.5M $9.9M +$3.6M +57.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $33.9M $11.4M +$1.4M +14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $32.5M $10.3M -$2M -16.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
Q1 2021 $34.5M $5.9M +$500K +9.26% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $34M $6.3M +$700K +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $33.3M $10M +$4.6M +85.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $28.7M $12.3M +$5.1M +70.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $23.6M $5.4M -$800K -12.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $24.4M $5.6M +$5.2M +1300% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-22
Q3 2019 $19.2M $5.4M +$100K +1.89% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-23
Q2 2019 $19.1M $7.2M +$1.2M +20% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-24
Q1 2019 $17.9M $6.2M +$2.8M +82.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-24
Q4 2018 $15.1M $400K -$2.1M -84% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q3 2018 $17.2M $5.3M +$700K +15.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-29
Q2 2018 $16.5M $6M +$500K +9.09% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-29
Q1 2018 $16M $3.4M -$100K -2.86% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $16.1M $2.5M -$2.9M -53.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-24
Q3 2017 $19M $4.6M $0 0% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-30
Q2 2017 $19M $5.5M +$600K +12.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 $18.4M $3.5M -$1.1M -23.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $19.5M $5.4M +$10.6M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $8.9M $4.6M +$1M +27.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $7.9M $4.9M -$10.6M -68.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $18.5M $4.6M -$700K -13.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $19.2M -$5.2M -$11.3M -185% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $30.5M $3.6M $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-31
Q2 2015 $30.5M $15.5M +$10.9M +237% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-01
Q1 2015 $19.6M $5.3M +$1M +23.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $18.6M $6.1M +$500K +8.93% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 $18.1M $3.6M -$1.6M -30.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $19.7M $4.6M -$400K -8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-03
Q1 2014 $20.1M $4.3M -$1.1M -20.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $21.2M $5.6M +$2M +55.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 $19.2M $5.2M +$800K +18.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-03
Q2 2013 $18.4M $5M +$700K +16.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 $17.7M $5.4M +$2.2M +68.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $15.5M $3.6M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q3 2012 $4.4M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $4.3M +$1.1M +34.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-05
Q1 2012 $3.2M -$100K -3.03% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q2 2011 $3.2M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 $3.3M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.